ReviewNature medicine2020
Ten recommendations for supporting open pathogen genomic analysis in public health.
Review in Nature medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
65 citing papers in PubMed, 116 citations in OpenAlex.
- Antibiotic-Specific Genotype-Phenotype Concordance and Cross-Database Interoperability in PublicInternational journal of molecular sciences · 2026Article
- Toward an Open Analysis Ecosystem for Plasmodium Genomic Epidemiology.The American journal of tropical medicine and hygiene · 2026Article
- High acceptability of a national platform for public health genomic data sharing and surveillance in Australia: a mixed methods study.BMC global and public health · 2026Article
- Conference report: The Third Bacterial Genome Sequencing Pan-European Network conference.FEMS microbiology letters · 2026Article
- Genetic Insights into the Economic Toll of Cell Line Misidentification: A Comprehensive Review.Medical sciences (Basel, Switzerland) · 2026Review
- Describing the outcomes and factors of using pathogen genomic results in public health.Frontiers in public health · 2026Article
- Article
- Biased sampling driven by bacterial population structure confounds machine learning prediction of antimicrobial resistance.PLoS biology · 2025Article
- Genomics in Epidemiology and Disease Surveillance: An Exploratory Analysis.Life (Basel, Switzerland) · 2025Review
- A graph homomorphism approach for unraveling histories of metastatic cancers and viral outbreaks under evolutionary constraints.Nature communications · 2025Article
- How to sustain a public-health genomics and bioinformatics workforce in Africa.Nature medicine · 2025Article
- Developing a contextually and culturally relevant benefit-sharing framework for pathogen genomic research and biobanking in africa: a deliberative expert approach.BMC medical ethics · 2025Article
- A global atlas and drivers of antimicrobial resistance in Salmonella during 1900-2023.Nature communications · 2025Article
- Estimating the deferred value of pathogen genomic data for secondary use.Scientific data · 2025Article
- Advantages of Software Containerization in Public Health Infectious Disease Genomic Surveillance.Emerging infectious diseases · 2025Article
- Use of integrated genomic surveillance by local public health authorities: Recommendations based on a mixed-methods study of current adoption, applications and success factors, Germany, 2023.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2025Article
- How does date-rounding affect phylodynamic inference for public health?PLoS computational biology · 2025Article
- Streamlining whole genome sequencing for clinical diagnostics with ONT technology.Scientific reports · 2025Article
- Developing a one health data integration framework focused on real-time pathogen surveillance and applied genomic epidemiology.One health outlook · 2025Article
- MoPSeq-DB: a user-friendly web application for genomic data management and analysis of marine mollusc pathogens.Database : the journal of biological databases and curation · 2025Article
5 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 3 institutions in 1 country.
Funding
Abstract
Increasingly, public-health agencies are using pathogen genomic sequence data to support surveillance and epidemiological investigations. As access to whole-genome sequencing has grown, greater amounts of molecular data have helped improve the ability to detect and track outbreaks of diseases such as COVID-19, investigate transmission chains and explore large-scale population dynamics, such as the spread of antibiotic resistance. However, the wide adoption of whole-genome sequencing also poses new challenges for public-health agencies that must adapt to support a new set of expertise, which means that the capacity to perform genomic data assembly and analysis has not expanded as widely as the adoption of sequencing itself. In this Perspective, we make recommendations for developing an accessible, unified informatic ecosystem to support pathogen genomic analysis in public-health agencies across income settings. We hope that the creation of this ecosystem will allow agencies to effectively and efficiently share data, workflows and analyses and thereby increase the reproducibility, accessibility and auditability of pathogen genomic analysis while also supporting agency autonomy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.